Take Action!

Recent develops the Biden Administration's review of the classification of cannabis has put the spotlight on national cannabis policy. News stories and commentaries about the impact of the historic change are full of misinformation with little focus on the impact rescheduling will have on medical cannabis patients. 

The truth is the rescheduling of cannabis alone does not restore rights to the millions of Americans that are using cannabis therapeutics or address barriers that millions more face. Congress will have to act. 

The good news is that we now are approaching policymakers about not only with a plan for national medical cannabis access but also with the validation of the US's top health agencies, that cannabis does in fact have medical value. 

This is a major milestone for medical cannabis advocacy, one we have been working toward for decades (take a bow)! This victory means that our role as advocates no longer requires us to prove that cannabis has medical value but instead we just have to steer policymakers toward a program that will meet the needs of patients. And YOU are the expert on this topic! 

For years, Americans for Safe Access has advocated for a national medical cannabis program that would create  uniformity in regulations, restore the rights of medical cannabis patients, create nationwide access for therapeutic use and research, and forge a new, purpose-built pathway for cannabis therapeutics. The nation is now ready for the framework !

Your federal representatives need to hear from you to understand: 

1) That the rescheduling of cannabis only validates the experience of patients but does not restore our rights

2) Congress will have to act for medical cannabis to advance

3) We have a plan!  

Your representatives want guidance on this issue and YOU are the best subject matter expert to fill this role. We need to flood Congress' inboxes with calls for action! 

Send a letter to your federal representatives now to ensure the future of medical cannabis!